Skip to content
SafetyScorer

Is Spironolactone safe?

Spironolactone

Spironolactone (Aldactone) has been used since 1960 and cut deaths by 30% in severe heart failure. Its main danger is high blood potassium, which can stop the heart, mostly in older people with weak kidneys or on ACE inhibitors or ARBs. In healthy young women taking it for acne, that risk is close to nil.

High confidence#29 of 82 medications
Updated
Spot a mistake?

#29of 82 medications

High confidence
Brands
Aldactone; CaroSpir (liquid, US); many generics
Type
Potassium-sparing diuretic and aldosterone blocker
Usual adult dose (US label)
25 to 50 mg once a day for heart failure; 25 to 100 mg a day for blood pressure; up to 400 mg for hyperaldosteronism
Potassium check
Within 1 week of starting or raising the dose (US label)
Boxed warning
None on the current Aldactone label
Breast growth in men
About 9 to 10% in the RALES heart failure trial
US prescriptions
About 13.4 million in 2024, ranked 50th (ClinCalc)
On the market
US since January 1960

How the score breaks down

The overall score is the weighted average of these factors. Scoring rules

  • Serious side effects30% of score

    66 out of 100, Fair

    High potassium is the serious risk. After the 1999 RALES trial, hyperkalaemia admissions among older Ontario heart failure patients on ACE inhibitors rose from 2.4 to 11.0 per 1,000, and deaths from 0.3 to 2.0 per 1,000. Breast growth affects about 1 in 10 men.

  • Overdose margin20% of score

    85 out of 100, Excellent

    The label gives an oral lethal dose above 1,000 mg per kg in animals. Acute overdose usually causes drowsiness, confusion, rash, nausea or diarrhoea; dangerous potassium levels are mainly a risk in people with kidney impairment.

  • Interactions15% of score

    52 out of 100, Weak

    The label says drugs that raise potassium can lead to severe hyperkalaemia, including ACE inhibitors, ARBs, NSAIDs, heparin, trimethoprim, potassium supplements and salt substitutes. Eplerenone is ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary; lithium, abiraterone and mitotane are flagged.

  • Dependence and misuse15% of score

    98 out of 100, Excellent

    No dependence, misuse potential or Drug dependenceThe body's adaptation to a drug taken regularly, so that stopping it suddenly causes withdrawal symptoms. It is not the same as addiction.More in the glossary. Not a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary.

  • Regulatory warnings10% of score

    75 out of 100, Good

    No Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary on the current Pfizer label, though older generic labels still print a box about tumours in rat studies. The MHRA warned in February 2016 about fatal hyperkalaemia when spironolactone is combined with ACE inhibitors or ARBs.

  • Track record10% of score

    95 out of 100, Excellent

    Aldactone was approved in the US on 21 January 1960 (NDA 012151). About 13.4 million US prescriptions in 2024, and landmark trials include RALES (1,663 patients, NEJM 1999).

Is spironolactone safe?

Spironolactone is one of the drugs that changed heart failure care, and for most people it is safe with simple checks. In the RALES trial, published in 1999, adding 25 mg a day to standard treatment in severe heart failure cut deaths from 46% to 35% over two years. It is also widely used for high blood pressure, fluid in liver disease, and, off-label, for acne in women. In 2024 it filled about 13.4 million US prescriptions (ClinCalc).

The danger is potassium. Spironolactone makes the kidneys hold on to it, and in someone with weak kidneys or on an ACE inhibitor or ARB, levels can climb high enough to stop the heart. We score it 76, above furosemide (70) but below hydrochlorothiazide (83). A lower score is not a reason to stop it; for heart failure it saves lives.

High potassium: who is really at risk

What happened after RALES shows the danger. Doctors in Ontario started prescribing spironolactone to many more older heart failure patients, often without the careful blood tests used in the trial. A 2004 NEJM study of people aged 66 and over on ACE inhibitors found:

19942001
Spironolactone prescriptions per 1,000 patients34149
Hospital admissions for high potassium per 1,0002.411.0
Deaths linked to high potassium per 1,0000.32.0

That was an estimated 73 extra hospital deaths in one Canadian province in a single year. In 2016 the MHRA warned again after a coroner's case in which a patient with heart failure, diabetes and kidney disease died of high potassium days after a low-dose ACE inhibitor was added.

The risk is very different in healthy people. A 2015 study of 974 young women taking spironolactone for acne found high potassium in 0.72% of blood tests, the same as the 0.76% rate in similar women not taking it.

The current US label says to check potassium within a week of starting or raising the dose and regularly after that. In heart failure it should only be started if potassium is 5.0 or below, and at a lower dose (25 mg every other day) when kidney function is reduced.

Hormonal side effects

Spironolactone blocks male hormones as well as aldosterone. That is why it helps hormonal acne in women, and why it causes trouble in men.

  • Breast growth in men: about 9% of men in RALES on an average of 26 mg a day. The label says it rises with dose, can take from one or two months to over a year to appear, and is usually reversible.
  • Erection problems and lower libido in men.
  • Irregular periods, breast tenderness and bleeding after the menopause in women.

Breast cancer is a common worry, and the evidence is reassuring. A UK study following more than a million women over 55 found no difference in breast cancer rates (hazard ratio 0.99).

For acne, the UK SAFA trial in 410 women found that 82% on spironolactone reported improvement at 24 weeks against 63% on placebo. Headaches were more common (20% against 12%), and there were no serious reactions.

Interactions to check

Most of the dangerous interactions are about potassium:

  • ACE inhibitors and ARBs such as lisinopril and losartan: often used together in heart failure on purpose, but only with regular blood tests.
  • Potassium supplements and salt substitutes like Lo-Salt: the label says to stop potassium supplements in heart failure patients starting spironolactone.
  • NSAIDs, heparin and trimethoprim (a common antibiotic for urinary infections): all can raise potassium.
  • Eplerenone: ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary together.
  • Lithium: levels rise; monitor.
  • Abiraterone for prostate cancer: not recommended, as spironolactone can raise PSA.

It also distorts some blood tests for digoxin, so labs need to use a different method.

Who should be careful

  • People with kidney disease, diabetes or heart failure, especially over 65.
  • Anyone with high potassium or Addison's disease, in whom it is ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary.
  • People with cirrhosis: the label says to start it in hospital, as sudden fluid shifts can bring on confusion or coma.
  • Pregnant women: in rats it feminised male fetuses, and the label says to avoid it. The NHS says it is not usually recommended in pregnancy.

Get urgent help for a slow or irregular heartbeat, muscle weakness or numbness, which can be signs of high potassium. Talk to your doctor or pharmacist before stopping or changing the dose, and before starting any new medicine or supplement.

How we scored it

Dependence (98), track record (95) and Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (85) are strong. Interactions (52) is the weakest factor, because so many common drugs and supplements push potassium up. Serious side effects (66) reflect the potentially fatal high-potassium risk in older, sicker patients, while regulatory warnings (75) reflect the MHRA alert without a current Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary.

Questions people ask

Is spironolactone safe for acne?

For healthy young women it has a good record. In the UK SAFA trial, 82% of women on spironolactone said their acne had improved at 24 weeks against 63% on placebo, with more headaches (20% against 12%) and no serious reactions. It is used off-label for acne in the US. It must not be taken in pregnancy, so talk to your doctor about contraception.

Do I need blood tests on spironolactone?

It depends on why you take it. The US label asks for a potassium check within a week of starting or raising the dose and regularly after that, which matters most in heart failure, kidney disease or with ACE inhibitors or ARBs. A 2015 study of 974 healthy young women on it for acne found high potassium no more often than in women not taking it, so many dermatologists test less. Follow your prescriber's plan.

Can I eat bananas on spironolactone?

In normal amounts, usually yes. The NHS says foods like bananas and avocados, and especially potassium salt substitutes such as Lo-Salt, can push potassium higher. Avoid salt substitutes and potassium supplements unless your doctor says otherwise.

Does spironolactone cause breast cancer?

The best evidence so far says no. A UK study of more than a million women over 55 found the same breast cancer rate in those who took spironolactone as in those who did not (hazard ratio 0.99). It can cause breast tenderness and, in men, breast growth.

Why does spironolactone cause breast growth in men?

It blocks male hormones as well as aldosterone. In the RALES heart failure trial, about 10% of men on 25 mg a day had breast growth or pain, against 1% on placebo. The label says the risk rises with the dose and it usually goes away after stopping. Eplerenone is a related drug that causes less of this; ask your doctor if it bothers you.

Sources

  1. 1.ALDACTONE (spironolactone) tablets prescribing information (opens in a new tab) · DailyMed / Pfizer, 2025
  2. 2.The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES) (opens in a new tab) · New England Journal of Medicine (Pitt et al.), 1999
  3. 3.Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study (opens in a new tab) · New England Journal of Medicine (Juurlink et al.), 2004
  4. 4.Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia (opens in a new tab) · MHRA Drug Safety Update, 2016
  5. 5.Effectiveness of spironolactone for women with acne vulgaris (SAFA) (opens in a new tab) · BMJ (Santer et al.), 2023
  6. 6.Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne (opens in a new tab) · JAMA Dermatology (Plovanich et al.), 2015
  7. 7.Spironolactone and risk of incident breast cancer in women older than 55 years (opens in a new tab) · BMJ (Mackenzie et al.), 2012
  8. 8.Spironolactone (opens in a new tab) · NHS, 2026
  9. 9.Spironolactone drug usage statistics, United States, 2014 to 2024 (opens in a new tab) · ClinCalc DrugStats (MEPS data), 2026
Spot a mistake?